Vivos Inc. (RDGL)
USD 0.12
(-2.79%)
USD 0.12
(-2.79%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -2.79 Million USD | -10.94% |
| 2022 | -2.51 Million USD | -0.64% |
| 2021 | -2.5 Million USD | -272.0% |
| 2020 | -672.52 Thousand USD | 49.43% |
| 2019 | -1.32 Million USD | 46.58% |
| 2018 | -2.48 Million USD | 4.86% |
| 2017 | -2.61 Million USD | 41.01% |
| 2016 | -4.43 Million USD | -72.12% |
| 2015 | -2.57 Million USD | -31.85% |
| 2014 | -1.95 Million USD | 45.38% |
| 2013 | -3.57 Million USD | 39.03% |
| 2012 | -5.87 Million USD | -129.16% |
| 2011 | -2.56 Million USD | 31.23% |
| 2010 | -3.72 Million USD | -46.11% |
| 2009 | -2.54 Million USD | 57.07% |
| 2008 | -5.93 Million USD | -129.28% |
| 2007 | -2.59 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -577.13 Thousand USD | 38.78% |
| 2024 Q2 | -522.31 Thousand USD | 9.5% |
| 2023 Q2 | -914.4 Thousand USD | -268.24% |
| 2023 FY | -2.79 Million USD | -10.94% |
| 2023 Q3 | -687.63 Thousand USD | 24.8% |
| 2023 Q4 | -942.79 Thousand USD | -37.11% |
| 2023 Q1 | -248.31 Thousand USD | 64.81% |
| 2022 Q1 | -747.49 Thousand USD | -242.2% |
| 2022 FY | -2.51 Million USD | -0.64% |
| 2022 Q4 | -705.65 Thousand USD | -154.69% |
| 2022 Q3 | -277.06 Thousand USD | 64.82% |
| 2022 Q2 | -787.53 Thousand USD | -5.36% |
| 2021 FY | -2.5 Million USD | -272.0% |
| 2021 Q1 | -235.09 Thousand USD | 20.38% |
| 2021 Q2 | -1.85 Million USD | -688.5% |
| 2021 Q3 | -194.58 Thousand USD | 89.5% |
| 2021 Q4 | -218.44 Thousand USD | -12.26% |
| 2020 Q2 | -128.45 Thousand USD | -6.71% |
| 2020 Q4 | -295.25 Thousand USD | -129.88% |
| 2020 Q1 | -120.37 Thousand USD | 62.91% |
| 2020 FY | -672.52 Thousand USD | 49.43% |
| 2020 Q3 | -128.44 Thousand USD | 0.01% |
| 2019 FY | -1.32 Million USD | 46.58% |
| 2019 Q3 | -607.2 Thousand USD | -250.95% |
| 2019 Q4 | -324.55 Thousand USD | 46.55% |
| 2019 Q1 | -225.2 Thousand USD | 86.94% |
| 2019 Q2 | -173.01 Thousand USD | 23.17% |
| 2018 Q2 | -341.9 Thousand USD | -19.26% |
| 2018 Q3 | -136.9 Thousand USD | 59.96% |
| 2018 FY | -2.48 Million USD | 4.86% |
| 2018 Q4 | -1.72 Million USD | -1159.36% |
| 2018 Q1 | -286.69 Thousand USD | 57.29% |
| 2017 Q3 | -961.79 Thousand USD | -55.34% |
| 2017 FY | -2.61 Million USD | 41.01% |
| 2017 Q4 | -671.22 Thousand USD | 30.21% |
| 2017 Q2 | -619.17 Thousand USD | -69.77% |
| 2017 Q1 | -364.71 Thousand USD | -377.72% |
| 2016 Q2 | -3.21 Million USD | -371.6% |
| 2016 FY | -4.43 Million USD | -72.12% |
| 2016 Q4 | 131.32 Thousand USD | 119.71% |
| 2016 Q3 | -666.41 Thousand USD | 79.3% |
| 2016 Q1 | -682.53 Thousand USD | 57.97% |
| 2015 Q3 | -293.81 Thousand USD | 11.25% |
| 2015 FY | -2.57 Million USD | -31.85% |
| 2015 Q2 | -331.06 Thousand USD | -0.68% |
| 2015 Q1 | -328.81 Thousand USD | 14.35% |
| 2015 Q4 | -1.62 Million USD | -452.71% |
| 2014 Q1 | -545.69 Thousand USD | -32.56% |
| 2014 FY | -1.95 Million USD | 45.38% |
| 2014 Q2 | -532.08 Thousand USD | 2.49% |
| 2014 Q4 | -383.91 Thousand USD | 22.18% |
| 2014 Q3 | -493.32 Thousand USD | 7.29% |
| 2013 Q2 | -1.18 Million USD | 20.87% |
| 2013 FY | -3.57 Million USD | 39.03% |
| 2013 Q1 | -1.49 Million USD | 2.0% |
| 2013 Q4 | -411.66 Thousand USD | 15.88% |
| 2013 Q3 | -489.38 Thousand USD | 58.64% |
| 2012 Q1 | -1.05 Million USD | -41.16% |
| 2012 FY | -5.87 Million USD | -129.16% |
| 2012 Q4 | -1.52 Million USD | 33.06% |
| 2012 Q3 | -2.27 Million USD | -125.92% |
| 2012 Q2 | -1 Million USD | 4.48% |
| 2011 Q1 | -717.32 Thousand USD | 44.5% |
| 2011 Q2 | -571.64 Thousand USD | 20.31% |
| 2011 Q3 | -524.58 Thousand USD | 8.23% |
| 2011 Q4 | -748.31 Thousand USD | -42.65% |
| 2011 FY | -2.56 Million USD | 31.23% |
| 2010 Q1 | -1.04 Million USD | -72.65% |
| 2010 FY | -3.72 Million USD | -46.11% |
| 2010 Q3 | -961.48 Thousand USD | -123.56% |
| 2010 Q4 | -1.29 Million USD | -34.43% |
| 2010 Q2 | -430.08 Thousand USD | 58.69% |
| 2009 FY | -2.54 Million USD | 57.07% |
| 2009 Q4 | -603.06 Thousand USD | 24.08% |
| 2009 Q3 | -794.39 Thousand USD | -36.84% |
| 2009 Q2 | -580.51 Thousand USD | -1.54% |
| 2009 Q1 | -571.68 Thousand USD | 74.98% |
| 2008 Q1 | -1.45 Million USD | 0.0% |
| 2008 Q4 | -2.28 Million USD | -125.37% |
| 2008 Q2 | -1.68 Million USD | -15.79% |
| 2008 Q3 | -1.01 Million USD | 39.71% |
| 2008 FY | -5.93 Million USD | -129.28% |
| 2007 FY | -2.59 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | -918.319% |
| IR-Med Inc. | -4.91 Million USD | 43.125% |
| Polarean Imaging plc | -12.55 Million USD | 77.755% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | 737.443% |
| Avitar, Inc. | 2.73 Million USD | 202.208% |
| AVITA Medical, Inc. | -40.4 Million USD | 93.087% |
| Manhattan Scientifics, Inc. | -703 Thousand USD | -297.318% |
| Össur hf. | 87.46 Million USD | 103.194% |
| Zecotek Photonics Inc. | -3.65 Million USD | 23.617% |
| QHSLab, Inc. | -240.15 Thousand USD | -1063.045% |
| Wellstar International, Inc. | -1.79 Million USD | -55.633% |
| Össur hf. | 87.46 Million USD | 103.194% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | 234.221% |
| Escalon Medical Corp. | -104.47 Thousand USD | -2573.481% |
| Aurora Spine Corporation | -446.19 Thousand USD | -525.991% |
| BrainsWay Ltd. | -4.92 Million USD | 43.309% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.45 Million USD | 70.472% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | 1104.74% |
| MicroPort Scientific Corporation | -516.16 Million USD | 99.459% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | -1067.869% |
| REMSleep Holdings, Inc. | -1.77 Million USD | -57.659% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -637.161% |
| Nanomix Corporation | -8.43 Million USD | 66.895% |
| Theraclion SA | -3.48 Million USD | 19.758% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | -295.055% |
| Positron Corporation | -1.36 Million USD | -105.265% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.06 Million USD | -35.265% |
| Lombard Medical, Inc. | -29.33 Million USD | 90.478% |
| ALR Technologies Inc. | -2.94 Million USD | 5.199% |
| Stratec SE | 25.26 Million USD | 111.054% |
| Vycor Medical, Inc. | 40.19 Thousand USD | 7049.68% |
| Heart Tronics, Inc. | 14.46 Million USD | 119.316% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | -2217.463% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 86.526% |
| SANUWAVE Health, Inc. | -540 Thousand USD | -417.249% |
| VMS Rehab Systems, Inc. | -68.66 USD | -4067983.309% |
| Guided Therapeutics, Inc. | -3.45 Million USD | 19.203% |
| Ingen Technologies, Inc. | -1.61 Million USD | -73.096% |
| Odyssey Group International, Inc. | 14.26 Million USD | 119.586% |
| United American Healthcare Corporation | -67 Thousand USD | -4068.875% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | -585.468% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | -340.082% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | -364.347% |
| Urologix, Inc. | -6.93 Million USD | 59.695% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | -121.093% |
| Nexeon MedSystems Inc. | -6.26 Million USD | 55.417% |
| SS Innovations International, Inc. | -20.66 Million USD | 86.486% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | -1113.14% |
| Smith & Nephew plc | 425 Million USD | 100.657% |
| NIOX Group Plc | 4.6 Million USD | 160.721% |
| Fuse Medical, Inc. | 383.82 Thousand USD | 827.723% |
| Broncus Holding Corporation | -33.22 Million USD | 91.592% |
| Brain Scientific Inc. | -9.6 Million USD | 70.93% |
| Pressure BioSciences, Inc. | -9.5 Million USD | 70.609% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | -4501.634% |